Status:

WITHDRAWN

A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Kidney Transplant Recipients

Lead Sponsor:

Johns Hopkins University

Conditions:

Medication Adherence

Transplant; Kidney

Eligibility:

All Genders

22+ years

Phase:

NA

Brief Summary

The investigators are interested in whether or not the use of a mobile health (mHealth) application increases the rate of immunosuppression medication adherence among adult kidney transplant recipient...

Detailed Description

In adult kidney transplant recipients, the leading predictor of rejection, kidney loss, and death is immunosuppressive medication nonadherence. An estimated one-third of kidney transplant recipients r...

Eligibility Criteria

Inclusion

  • Adults (≥22 years)
  • Receive a kidney transplant at the Johns Hopkins Hospital

Exclusion

  • Non-English speaking participants

Key Trial Info

Start Date :

September 30 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 12 2020

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT03427008

Start Date

September 30 2018

End Date

November 12 2020

Last Update

September 23 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Johns Hopkins Hospital

Baltimore, Maryland, United States, 21205

A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Kidney Transplant Recipients | DecenTrialz